IMedis is an artificial intelligence platform analyzing medical information to identify previously undetected patients that are candidates for early and preventative care. Our vision is to increase early detection rates, help deliver better clinical outcomes, lower medical costs and mitigate clinical risks. We are seeking collaboration opportunities with medical institutions in the US for the purpose of joint research and development of our future products.
Founded in early 2018, IMedis was created with the aim of improving early detection of cancer and other life-threatening conditions via our novel approach of comparing “vision” and “text” for discrepancies. With radiology teams challenged by ever-increasing workloads, we uniquely solve for doing more with less – improving performance while reducing risk.
Total Funding: $1,300,000
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 1 to 25
Founded: 2018
